CORC

在结果中检索

CORC

浏览/检索结果: 共68条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Microstructure and Mechanical Properties of an Austenitic Heat-Resistant Steel after Service at 570 degrees C and 25.4 MPa for 18 Years 期刊论文
JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE, 2021, 页码: 9
作者:  Yang, Xu;  Yu, Chengwei;  Yang, Xisheng;  Yan, Kai;  Qian, Gong
收藏  |  浏览/下载：58/0  |  提交时间：2021/03/15
New design and fabrication of Cu3SnS4@C nanostructure for high efficient removal of anionic dye 期刊论文
Materials Letters, 2019, 卷号: 238, 期号: -, 页码: 183-186
作者:  Xue Li;  Xiaofei Dong;  Fangting Liu;  Yan Li;  Gongxuan Lu
收藏  |  浏览/下载：61/0  |  提交时间：2019/11/15
A novel pancreatic cancer model originated from transformation of acinar cells in adult tree shrew, a primate-like animal 期刊论文
DISEASE MODELS & MECHANISMS, 2019, 卷号: 12, 期号: 4
作者:  Tu, Qiu;  Yang, Dong;  Zhang, Xianning;  Jia, Xintong;  An, Sanqi
收藏  |  浏览/下载：38/0  |  提交时间：2019/12/04
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：50/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：41/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
Wirelessly Coupled Fiber-Bragg-Grating Sensor for Bushing-Temperature Monitoring 期刊论文
Guangxue Xuebao/Acta Optica Sinica, 2019, 卷号: 39, 期号: 9
作者:  He, Wei;  Zhang, Cui;  Tong, Xinglin;  Deng, Chengwei;  Liu, Fang
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace